Dan Brennan
Stock Analyst at TD Cowen
(4.14)
# 501
Out of 4,981 analysts
110
Total ratings
53.41%
Success rate
13.57%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Maintains: Buy | $10 → $12 | $7.96 | +50.75% | 7 | Sep 12, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $13 → $15 | $12.61 | +18.95% | 1 | Aug 6, 2025 | |
| CAI Caris Life Sciences | Initiates: Buy | $32 | $34.06 | -6.05% | 1 | Jul 14, 2025 | |
| GH Guardant Health | Maintains: Buy | $56 → $60 | $54.90 | +9.30% | 2 | May 1, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $135 → $110 | $123.95 | -11.25% | 4 | May 1, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $2.5 | $2.65 | -5.66% | 4 | Mar 21, 2025 | |
| TEM Tempus AI | Reinstates: Buy | $74 | $86.38 | -14.33% | 2 | Feb 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $53.94 | +59.44% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $168.51 | +3.85% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $152.89 | +63.52% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $72 → $70 | $30.91 | +126.46% | 1 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $166 → $177 | $95.12 | +86.08% | 12 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $144 | $82.87 | +73.77% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $363 → $410 | $295.39 | +38.80% | 3 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $315 | $190.05 | +65.75% | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $160 | $123.24 | +29.83% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $7.24 | +314.36% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $12.31 | +151.83% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $479.46 | +37.24% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $43.97 | +15.99% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $0.38 | +646.47% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $12.64 | +153.16% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $159.87 | +241.54% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $3.69 | +89.70% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.17 | +1,182.05% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $175.01 | +32.56% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,259.54 | -30.13% | 3 | Oct 7, 2020 |
NeoGenomics
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $7.96
Upside: +50.75%
Adaptive Biotechnologies
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $12.61
Upside: +18.95%
Caris Life Sciences
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $34.06
Upside: -6.05%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $56 → $60
Current: $54.90
Upside: +9.30%
GeneDx Holdings
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $123.95
Upside: -11.25%
Maravai LifeSciences Holdings
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $2.65
Upside: -5.66%
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $86.38
Upside: -14.33%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $53.94
Upside: +59.44%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $168.51
Upside: +3.85%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $152.89
Upside: +63.52%
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $30.91
Upside: +126.46%
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $95.12
Upside: +86.08%
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $82.87
Upside: +73.77%
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $295.39
Upside: +38.80%
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $190.05
Upside: +65.75%
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $123.24
Upside: +29.83%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $7.24
Upside: +314.36%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $12.31
Upside: +151.83%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $479.46
Upside: +37.24%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $43.97
Upside: +15.99%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $0.38
Upside: +646.47%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $12.64
Upside: +153.16%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $159.87
Upside: +241.54%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $3.69
Upside: +89.70%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.17
Upside: +1,182.05%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $175.01
Upside: +32.56%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,259.54
Upside: -30.13%